<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940523-0-00041</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4700 -->  <!-- PJG ITAG l=81 g=1 f=1 --> 3. Food Advisory Committee Discussions Regarding Potential Horizontal Transfer of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=3 --> Kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 -->  Gene  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> As part of its discussion of the scientific issues related to the evaluation of Calgene's genetically engineered tomato, the Food Advisory Committee discussed the possibility that the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene might be transferred to microorganisms in the GI tract and in the environment (Ref. 1).  <!-- PJG 0012 frnewline --> The committee members concluded that transfer of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene consumed as a component of tomatoes to microorganisms in the GI tract was highly unlikely based on published data in the scientific literature. Similarly, the committee members judged that the potential for transfer of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene from plants to microorganisms in the environment is highly unlikely based on the members' knowledge of mechanisms of gene transfer. In addition, members of the committee pointed out that the rate at which such transfer could take place, if at all, was of so small a magnitude that, coupled with the high prevalence of kanamycin resistant organisms already present in the environment, it would not cause a significant environmental impact.  <!-- PJG 0012 frnewline --> Some members of the committee, while convinced by the information presented at the meeting that the transfer of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene from tomato plants to microorganisms in the soil was improbable, expressed concern regarding the use of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene in other crops that may be grown on a wide scale. In addition, some committee members were concerned that a determination of safety with regard to the use of  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene in Calgene's tomato might signal to producers that it is now permissible to use the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene in other crops. In light of such concerns, these committee members advised that use of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene in other crops should be evaluated on a case-by-case basis.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> 4. Agency Conclusions  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The agency has considered the recommendations of the members of the Food Advisory Committee. The agency agrees that the potential transfer of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene, as well as other antibiotic resistance marker genes, from crops to microorganisms should be evaluated on a case-by-case basis. As noted, Calgene petitioned for the use of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene product, APH(3 <!-- PJG 0020 minuteslatlong --> &rsquo;)II, in the development of genetically engineered cotton and oilseed rape in addition to tomato. As discussed below, the agency has evaluated data and information concerning horizontal transfer of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene from its use in all three crops. This is consistent with the committee's advice that safety of the use of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene be evaluated on a case-by-case basis. In addition, Calgene's petition seeks to amend the food additive regulations to permit the use of APH(3 <!-- PJG 0020 minuteslatlong --> &rsquo;)II only in tomato, cotton, and oilseed rape; approval of Calgene's petition would not mean that developers could use the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene in crops other than those identified in the petition.  <!-- PJG 0012 frnewline --> FDA has also evaluated the information submitted by Calgene and has determined that the probability of transfer of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene to gut microflora is remote and that even under worst-case conditions, the number of microorganisms that would be converted to kanamycin resistance is negligible when compared to the reported prevalence of gut microflora that are already resistant to kanamycin (Ref. 35). This conclusion applies to both humans and animals. The agency has determined that exposure to foods that contain the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene will not compromise the efficacy of antibiotic treatment because the likelihood of increasing the number of antibiotic resistant microorganisms is extremely low. Further, the agency has determined that there is no evidence that free DNA containing the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene, even if present, can transform cells lining the GI tract (Ref. 2).  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            